R&D expense · 2011–2025
Niagen Bioscience R&D expense
$6.3M+5.2% · FY2025
Niagen Bioscience (NAGE) reported $6.3M in R&D expense for fiscal 2025, +5.2% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $6.3M | +5.2% | Open → |
| FY20242024-12-31 | $6.0M | +21.3% | Open → |
| FY20232023-12-31 | $5.0M | +2.7% | Open → |
| FY20222022-12-31 | $4.8M | +25.9% | Open → |
| FY20212021-12-31 | $3.8M | +12.2% | Open → |
| FY20202020-12-31 | $3.4M | −22.7% | Open → |
| FY20192019-12-31 | $4.4M | −19.3% | Open → |
| FY20182018-12-31 | $5.5M | +36.7% | Open → |
| FY20172017-12-30 | $4.0M | +58.8% | Open → |
| FY20162016-12-31 | $2.5M | +182.9% | Open → |
| FY20152016-01-02 | $891,601 | +73.6% | Open → |
| FY20142015-01-03 | $513,671 | +283.2% | Open → |
| FY20132013-12-28 | $134,040 | −5.6% | Open → |
| FY20122012-12-29 | $142,000 | +46.7% | Open → |
| FY20112011-12-31 | $96,788 | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +34.8%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience R&D expense |url=https://companiesranked.com/en/company/niagen-bioscience/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience R&D expense. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-niagen-bioscience-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001386570-26-000013 · March 4, 2026
{{cite web |title=Niagen Bioscience R&D expense — 10-K (0001386570-26-000013) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.